BSPED2021

24 November 2021

08:50-09:00Welcome and Introduction
Chair(s): Anitha Kumaran (Southampton, UK)
09:00-10:15CME Session 1
Chair(s): Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
09:00Epidemiology of adrenal crisis in children
09:30Kidney speaks - Interpreting kidney function tests in disorders of salt and water balance
10:00Q&A
10:15-10:45CME Case Presentations 1
Chair(s): Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
10:15OC1.1Severe hypercalcaemia in Williams-Beuren syndrome
10:25OC1.2Two cases of functioning adrenocortical tumours secondary to TP53 variants
10:35Q&A
10:45-11:00Break
11:00-12:15CME Session 2
Chair(s): Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
11:00Update in the recognition and management of adolescent PCOS
11:30Approach to a viralising girl in puberty
12:00Q&A
12:15-12:45CME Case Presentations 2
Chair(s): Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
12:15OC2.1Pitfalls and challenges in the diagnosis and management of Cushing’s disease in children: An interesting case
12:25OC2.2Two cases of McCune-Albright Syndrome with multisystem involvement
12:35Q&A
12:45-12:55CSAC Trainee Representative
12:55-13:55Lunch
13:55-15:10CME Session 3
Chair(s): Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
13:55Controversies in management of neonatal hypoglycaemia
14:25Hypothalamic obesity post cancer treatment - optimising outcomes
14:55Q&A
15:10-15:15CME Case Presentations 3
Chair(s): Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
15:10OC3.1Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome (ROHHAD-NET): Case series & learning points
15:15OC3.2Variable responses to sulfonylurea treatment in siblings from the same family with monogenic diabetes due to HNF1A mutation
15:20Q&A
15:25-15:40Break
15:40-16:40CME Session 4
Chair(s): Anitha Kumaran (Southampton, UK) and Dr Sophia Sakka (London, UK)
15:40Updating Diabetes care with advances in diabetes technology and digital health
16:05Hypoglycemia unawareness in type 1 diabetes – lessons learnt
16:30Q&A
16:40-16:55CME Officer's Update

25 November 2021

07:45-08:45Industry Sponsored Satellite Symposium
08:45-09:00Break
09:00-09:10Welcome from BSPED President and Chair
Chair(s): Tabitha Randell (Nottingham, UK) & Senthil Senniappan (Liverpool, UK)
09:10-10:40Endocrine Oral Comms 1
Chair(s): Hoong-Wei Gan (London, UK) and Justin Davies (Southampton, UK)
09:10OC4.1Dominant Mutations in CCDC141 are found by Whole Exome Sequencing to be a Common Cause of Self-Limited Delayed Puberty
09:18OC4.2Pseudohypoparathyroidism type 1A and 1B: presentation, phenotypes and phenotype-genotype associations
09:26OC4.3Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity
09:32OC4.4Does Inflammation Underpin Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Novel Non-Invasive Biomarker and Pathway Discovery in Adolescent PCOS
09:40Q&A
09:48OC4.5The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population
09:56OC4.6The management of adrenal cell carcinoma in the United Kingdom at a single centre: a 25 year experience
10:04OC4.7The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study
10:12OC4.8Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008
10:20OC4.9The use of Liraglutide in the treatment of childhood obesity
10:28Q&A
09:10-10:40Diabetes Symposium 1
Chair(s): Tabitha Randell (Nottingham, UK) and Amanda Peacock (Leeds, UK)
09:10Low carbohydrate diets in type 1 diabetes
09:30Eating disorder risk in weight management
09:50Low carbohydrate diets in type 2 diabetes
10:10Q&A
10:40-10:55Break
10:55-11:55Endocrine Symposium 1
Chair(s): Guftar Shaikh (Glasgow, UK) and Senthil Senniappan (Liverpool, UK)
10:55Fertility preservation in boys
11:15Turner syndrome adolescence and beyond
11:35Q&A
10:55-11:55Diabetes Symposium 2
Chair(s): Noina Abid (Belfast, Northern Ireland) and Neil Wright (Sheffield, UK)
10:55Controversies in the management of DKA
11:15Type 1 diabetes: moving into adulthood
11:35Q&A
11:55-12:25Endocrine Oral Comms 2
Chair(s): Renuka Dias (Birmingham, UK) and Pooja Sachdev (Nottingham, UK)
11:55OC5.1Evaluating UK Referral Criteria for Children with Short Stature in a Tertiary Paediatric Endocrinology Centre
12:00OC5.2Evaluation of the discrepancy between free thyroxine (FT4) reference ranges and the impact on clinical investigation of central hypothyroidism
12:05OC5.3An Investigation Of Androgen-responsive Non-coding RNAs In Boys With Atypical Genitalia Without Genetic Variants in the Androgen Receptor (AR)
12:10OC5.4Virtual exercise sessions: An innovative way of promoting physical activity in children and young people with obesity
12:15OC5.5B-cell class switching in trans- and cis-gendered healthy young people is differentially influenced by sex hormones
12:20Q&A
11:55-12:25Diabetes Oral Comms 1
Chair(s): Melanie Kershaw (Birmingham, UK) and May Ng (Liverpool, UK)
11:55OC7.1Utility of glycated haemoglobin in assessing abnormal glucose homeostasis in children and adolescents with obesity undergoing oral glucose tolerance test
12:00OC7.2Multi-Centre Service Evaluation of Presentation of Newly Diagnosed Type 1 Diabetes in Children in the U.K. During the COVID-19 Pandemic
12:05OC7.3Hybrid closed-loop in children and young people with type 1 diabetes improves glycaemic management and quality of life measures
12:10OC7.4Patient experiences of the changes made to the Cardiff and Vale University Health Board Paediatric Diabetes service due to COVID-19
12:15OC7.5Screening for Eating Disorders in Young People with Type 1 Diabetes
12:20Q&A
12:25-12:40Break
12:40-13:10Industry Sponsored Expert Insights Session
12:40-13:10Industry Sponsored Expert Insights Session
13:10-14:10Lunch
14:10-14:40Awards Session - James M Tanner Award
Chair(s): Tabitha Randell (Nottingham, UK) and Senthil Senniappan (Liverpool, UK)
14:40-14:55Break
14:55-15:55Endocrine Symposium 2
Chair(s): Gary Butler (London, UK) and Bindu Avatapalle (Cardiff, UK)
14:55GnRH analogues for gender dysphoria
15:15Using AMH and inhibin B assays in children and young people
15:35Q&A
14:55-15:55Diabetes Symposium 3
Chair(s): Ritika Kapoor (London, UK) and Chizo Agwu (Birmingham, UK)
14:55Early detection of neonatal diabetes
15:15100 years of insulin - is it time for a UK Type 1 diabetes screening strategy?
15:35Q&A
15:55-16:10Break
16:05-16:45Personal Practice Session
Chair(s): Mehul Dattani (London, UK) and Nikki Davis (Southampton, UK)
16:05Medical management of T2DM in adolescents
16:20Management of thyroid nodules in children
16:35Q&A
16:10-16:40Endocrine Oral Comms 3
Chair(s): Dinesh Giri (Bristol, UK) and Nils Krone (Sheffield, UK)
16:10OC6.1Novel dominant negative GH receptor variants provide important insights into GH receptor physiology
16:15OC6.2Body composition in adults with genetically-confirmed Silver-Russell syndrome
16:20OC6.3Topiramate as a treatment option in managing obesity complicated by idiopathic intracranial hypertension and chronic migraine in children and adolescents
16:25OC6.4Final height SDS of paediatric patients with ESRF that underwent renal transplantation
16:30OC6.5Highlighting POLE1 mutations as a cause of adrenal insufficiency
16:35Q&A
16:40-16:55Break
16:55-18:15AGM

26 November 2021

09:00-09:30Endocrine Nurses Business Meeting
09:30-11:00Diabetes Symposium 4
Chair(s): Evelien Gevers (London, UK) and Fiona Campbell (Leeds, UK)
09:30Optimising time in range using continuous glucose monitoring
09:50Real world use of the closed loop insulin delivery system
10:10Personalising insulin therapy using smart pumps, pens and automated insulin delivery systems
10:30Q&A
09:30-11:00Endocrine Symposium 3
Chair(s): Lee Martin (London, UK) and Isabelle Sharratt (London, UK)
09:30Non-medical prescribing: how can you make a difference to your service as a non-medical prescriber?
09:50Advanced nurse practice: what is advanced nurse practice?
10:10Running a Paediatric Endocrine Nurse clinic: benefits and tips for success
10:30Q&A
11:00-11:15Break
11:15-12:45Diabetes Oral Comms 2
Chair(s): Chris Moudiotis (Exeter, UK) and Rathi Prasad (London, UK)
11:15OC8.1Cystic fibrosis related diabetes (CFRD): could Cystic Fibrosis Transport Receptor (CFTR) modulators be the answer?
11:23OC8.2The cost of diabetes school training was halved whilst training 25% more staff during COVID-19 using multi-media interactive care plans
11:31OC8.3Nottingham’s Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes
11:39OC8.4Developing a clinical decision aid for paediatric diabetic ketoacidosis: the DKA Calculator
11:47Q&A
11:55OC8.5Permanent neonatal diabetes due to KCNJ11 mutation: early successful transition to Glibenclamide and stable glucose profile with multiple daily dosing
12:03OC8.6Evaluation of the diabetes education app
12:11OC8.7HENRY: High HbA1c service Evaluation 2016-2019: New “tipping point” in contactRequired for CYPwD
12:19OC8.8Barriers to uploading diabetes technology at home
12:27OC8.9Virtual Sessions 'Cook and Count' for Young People with Type 1 Diabetes, Using PDSA Cycles, Meeting Young Peoples Wishes
12:35Q&A
11:15-12:15Endocrine Oral Comms 4
Chair(s): Susan Sparrow (Cambridge, UK) and Karis Reyes (Cambridge, UK)
11:15OC9.4Changes in trends in Short Synacthen Test use over a decade - a single centre experience
11:22OC9.1Variability in the diagnosis of growth hormone deficiency using dynamic tests. Time for robust pre-test criteria?
11:29OC9.2Sex Steroid Priming for Growth Hormone Stimulation Testing – A Systematic Review
11:36OC9.3Investigating paediatric weight management apps
11:43OC9.5Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy: Results of a UK patient survey
11:50OC9.6'Think Adrenal': An innovative trust-wide safety and education programme designed for the care of patients with adrenal insufficiency
11:57Q&A
12:15-12:45Presentations from Previous Award Winners
Chair(s): Christina Wei (London, UK) and Jo Blair (Liverpool, UK)
12:15BSPED Research & Innovation Award Winner 2017
12:23BSPED Research & Innovation Award Winner 2018
12:31BSPED Research & Innovation Award Winner 2018
12:39Q&A
12:45-13:15Lunch
13:15-13:45Industry Sponsored Expert Insights Session
13:45-14:00Break
14:00-15:30Diabetes Symposium 5
Chair(s): Mars Skae (Manchester, UK) and Nicola Bridges (London, UK)
14:00Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
14:20Evaluation and Management of Genetic forms of Obesity
14:40Psychoeducation and changing behaviour: Knowing how doesn’t always mean action
15:00Q&A
14:00-15:30Endocrine Symposium 4
Chair(s): Raja Padidela (Manchester, UK) and Renuka Ramakrishnan (Liverpool, UK)
14:00Interpretation of abnormal thyroid function tests in children and adolescents
14:20Metabolic bone disease of prematurity: recognition, prevention and treatment
14:40Newer treatment options for childhood obesity management
15:00Q&A
15:30-15:45Break
15:45-16:00BSPED 2021 Awards Session
Chair(s): Sabah Alvi (Leeds, UK) and Helen Storr (London, UK)
16:00-16:15Close of Meeting
Chair(s): Senthil Senniappan (Liverpool, UK)